| Study |
N of patients |
Stimulation parameters |
N of pulses / session |
N of sessions |
Outcome measure |
| Lomarev et al., [41] |
18 |
25 Hz – 100% RMT |
1200 |
8 |
UPDRS-III |
| del Olmo et al., [60] |
13 |
10 Hz – 90% RMT |
450 |
10 |
UPDRS-III |
| Rektorova et al., [43] |
6 |
10 Hz – 90% RMT |
1350 |
5 |
UPDRS-III; FOG |
| Sedlackova et al., [69] |
10 |
10 Hz – 100% RMT |
1350 |
3 |
UPDRS-III |
| Pal et al., [62] |
22 |
5 Hz – 90% RMT |
600 |
10 |
UPDRS-III |
| Nardone et al., [63] |
4 |
1 Hz – below AMT |
1800 |
1 |
UPDRS-III |
| Spagnolo et al., [53] |
27 |
10 Hz – 100% RMT |
1680 |
12 |
UPDRS-III |
Table 3: rTMS studies in PD: DLPFC as target area. rTMS, repetitive Transcranial Magnetic Stimulation; PD, Parkinson’s Disease; DLPFC, Dorsolateral Prefrontal Cortex; Hz, Hertz; RMT, resting motor threshold; UPDRS (III/IV), Unified Parkinson’s Disease Rating Scale (Section III/ IV); FOG, Freezing of Gait |
